Analgesics and Anti-inflammatory Drugs Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Analgesics and Anti-inflammatory Drugs. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Analgesics and Anti-inflammatory Drugs Indian Medical PG Question 1: Which of the following is NOT an indication for the use of NSAIDs?
- A. As an analgesic
- B. In peptic ulcer disease (Correct Answer)
- C. Rheumatoid arthritis
- D. Osteoarthritis
Analgesics and Anti-inflammatory Drugs Explanation: **Explanation:**
The correct answer is **B. In peptic ulcer disease**. NSAIDs are generally **contraindicated** in patients with peptic ulcers because they inhibit the enzyme Cyclooxygenase-1 (COX-1). COX-1 is responsible for synthesizing cytoprotective prostaglandins ($PGE_2$ and $PGI_2$) in the gastric mucosa. These prostaglandins reduce gastric acid secretion, increase bicarbonate production, and maintain mucosal blood flow. By inhibiting them, NSAIDs compromise the gastric mucosal barrier, leading to erosions, ulceration, and potential perforation or hemorrhage.
**Why the other options are incorrect:**
* **A. As an analgesic:** NSAIDs are first-line agents for mild-to-moderate pain (e.g., headache, dysmenorrhea, or post-operative pain) by inhibiting $PGE_2$ synthesis, which sensitizes pain receptors.
* **C & D. Rheumatoid Arthritis and Osteoarthritis:** NSAIDs are mainstay symptomatic treatments for these conditions. They reduce joint inflammation, swelling, and stiffness by inhibiting COX-2 at the site of inflammation.
**High-Yield Clinical Pearls for NEET-PG:**
* **Mechanism of Gastric Injury:** NSAIDs cause damage via two pathways: systemic inhibition of protective prostaglandins and direct local irritation (topical effect).
* **Prophylaxis:** If an NSAID must be used in a high-risk patient, **Misoprostol** (a $PGE_1$ analog) or a Proton Pump Inhibitor (PPI) is co-administered for mucosal protection.
* **Selective COX-2 Inhibitors (e.g., Celecoxib):** These carry a lower risk of GI ulcers but are associated with increased cardiovascular risks.
* **Aspirin Sensitivity:** NSAIDs can trigger "Aspirin-Exacerbated Respiratory Disease" (AERD) in asthmatic patients due to a shift in arachidonic acid metabolism toward the leukotriene pathway.
Analgesics and Anti-inflammatory Drugs Indian Medical PG Question 2: What is the mechanism of action of Aspirin?
- A. Inhibition of PGI2 formation
- B. Inhibition of TXA2 formation (Correct Answer)
- C. Stimulation of TXA2 formation
- D. Stimulation of platelet aggregation
Analgesics and Anti-inflammatory Drugs Explanation: **Explanation:**
**Mechanism of Action:**
Aspirin (Acetylsalicylic acid) acts by **irreversibly inhibiting the enzyme Cyclooxygenase (COX-1 and COX-2)** via acetylation of a serine residue. In platelets, this leads to the inhibition of **Thromboxane A2 (TXA2)** synthesis. Since platelets are anucleated and cannot synthesize new enzymes, the inhibition lasts for the entire lifespan of the platelet (approx. 7–10 days). TXA2 is a potent vasoconstrictor and platelet aggregator; thus, its inhibition results in an anti-thrombotic effect.
**Analysis of Options:**
* **Option B (Correct):** Aspirin reduces TXA2 levels, which is the primary mechanism for its use in secondary prophylaxis of MI and stroke.
* **Option A (Incorrect):** While aspirin can inhibit PGI2 (Prostacyclin) in vascular endothelium, PGI2 is a vasodilator and anti-aggregatory agent. At low doses, aspirin selectively inhibits TXA2 more than PGI2 because endothelial cells can regenerate COX enzymes, unlike platelets.
* **Option C & D (Incorrect):** Aspirin inhibits, rather than stimulates, TXA2 formation. Consequently, it inhibits (rather than stimulates) platelet aggregation.
**High-Yield NEET-PG Pearls:**
1. **Low-dose Aspirin (75–150 mg):** Exhibits anti-platelet effects (selective TXA2 inhibition).
2. **Zero-order Kinetics:** Aspirin follows zero-order elimination at high/toxic doses.
3. **Reye’s Syndrome:** Aspirin is contraindicated in children with viral infections (Varicella/Influenza) due to the risk of hepatic encephalopathy.
4. **Aspirin Triad (Samter’s Triad):** Asthma, Nasal polyposis, and Aspirin hypersensitivity.
5. **Antidote:** There is no specific antidote; treatment for toxicity involves gastric lavage and **urinary alkalinization** (using Sodium Bicarbonate) to enhance excretion.
Analgesics and Anti-inflammatory Drugs Indian Medical PG Question 3: What is the mechanism of analgesia?
- A. Nociceptin stimulation (Correct Answer)
- B. Nooistatln stimulation
- C. Nicotinic & cholinergic receptors
- D. Anandamide receptors
Analgesics and Anti-inflammatory Drugs Explanation: ### Explanation
**Correct Option: A. Nociceptin stimulation**
Nociceptin (also known as Orphanin FQ) is an endogenous neuropeptide that acts on the **NOP receptor** (Nociceptin/Orphanin FQ peptide receptor). Although it belongs to the opioid receptor family, it does not bind to classical $\mu$, $\kappa$, or $\delta$ receptors. Nociceptin acts as a potent modulator of pain. While its effects are complex (it can be pro-nociceptive in the spinal cord), its stimulation in specific supraspinal pathways and its role in modern drug development (like **Cevidopline**) are targeted for producing potent analgesia without the typical side effects of classical opioids, such as respiratory depression or physical dependence [3].
**Incorrect Options:**
* **B. Nooistatln stimulation:** This is a distractor term with no recognized physiological role in pain modulation or pharmacology.
* **C. Nicotinic & cholinergic receptors:** While nicotinic agonists (like Epibatidine) have shown analgesic properties, they are not the primary mechanism for standard analgesia and are limited by high toxicity. Cholinergic stimulation generally relates to the parasympathetic nervous system rather than direct sensory pain inhibition.
* **D. Anandamide receptors:** Anandamide is an endogenous cannabinoid that binds to **CB1 and CB2 receptors**. While it plays a role in the "endocannabinoid system" for pain relief, "Anandamide receptors" is a misnomer; the receptors are termed Cannabinoid receptors.
**NEET-PG High-Yield Pearls:**
* **NOP Receptor:** Formerly known as the "Orphan" receptor (ORL-1). It is G-protein coupled ($G_i/G_o$).
* **Triple/Mixed Agonists:** New research focuses on ligands that target $\mu$ and NOP receptors simultaneously to provide "safer" analgesia [3].
* **Endogenous Opioids:** Remember the pairs: **$\mu$** (Endorphins), **$\delta$** (Enkephalins), **$\kappa$** (Dynorphins), and **NOP** (Nociceptin) [1], [2]. Activation of these receptors on nociceptive fibers leads to decreased Ca2+ influx and increased K+ conductance, reducing sensory transmission [2].
Analgesics and Anti-inflammatory Drugs Indian Medical PG Question 4: Which of the following is a new IL-1 antagonist used in rheumatoid arthritis?
- A. Anakinra (Correct Answer)
- B. Rituximab
- C. Teriparatide
- D. Adalimumab
Analgesics and Anti-inflammatory Drugs Explanation: **Explanation:**
**Anakinra** is the correct answer because it is a recombinant, non-glycosylated form of the human **Interleukin-1 receptor antagonist (IL-1Ra)**. In Rheumatoid Arthritis (RA), IL-1 is a key pro-inflammatory cytokine that mediates cartilage destruction and bone resorption. Anakinra competitively inhibits the binding of IL-1α and IL-1β to the IL-1 type I receptor, thereby reducing the inflammatory response.
**Analysis of Incorrect Options:**
* **Rituximab (Option B):** This is a chimeric monoclonal antibody against **CD20**, a protein found primarily on the surface of B-cells. It is used in RA cases refractory to TNF inhibitors.
* **Teriparatide (Option C):** This is a recombinant form of **Parathyroid Hormone (PTH)**. It is an anabolic agent used for Osteoporosis, not an anti-inflammatory for RA.
* **Adalimumab (Option D):** This is a fully human monoclonal antibody directed against **TNF-α** (Tumor Necrosis Factor-alpha), not IL-1 [1].
**High-Yield NEET-PG Pearls:**
* **Other IL-1 Inhibitors:** Apart from Anakinra, newer agents include **Canakinumab** (monoclonal antibody against IL-1β) and **Rilonacept** (IL-1 trap).
* **Clinical Use:** Anakinra is less commonly used than TNF inhibitors due to its shorter half-life (requires daily subcutaneous injections) and lower efficacy in RA.
* **Contraindication:** Never combine IL-1 antagonists with TNF inhibitors (like Adalimumab or Etanercept) due to a significantly increased risk of serious infections [2].
* **Side Effect:** Injection site reactions are the most common adverse effect.
DMARDs include a diverse group of small molecule non-biologicals and biological agents used to retard the progression of arthritic tissue destruction [3].
Analgesics and Anti-inflammatory Drugs Indian Medical PG Question 5: Which of the following NSAIDs is preferred in the treatment of dysmenorrhea?
- A. Indomethacin
- B. Ketorolac
- C. Mefenamic acid (Correct Answer)
- D. Naproxen
Analgesics and Anti-inflammatory Drugs Explanation: **Explanation:**
**Mefenamic acid** (Option C) is the preferred NSAID for the treatment of primary dysmenorrhea. The underlying pathophysiology of dysmenorrhea involves the overproduction of prostaglandins (specifically $PGF_{2\alpha}$) in the endometrium, leading to uterine hypercontractility and ischemia. Mefenamic acid is uniquely effective because it possesses a **dual mechanism of action**:
1. It inhibits the enzyme **Cyclooxygenase (COX)**, thereby reducing the synthesis of prostaglandins.
2. It acts as an **antagonist at prostaglandin receptors**, directly blocking the action of pre-formed prostaglandins on the myometrium.
**Analysis of Incorrect Options:**
* **A. Indomethacin:** While a potent COX inhibitor, it is associated with a high incidence of systemic side effects (GI distress, frontal headaches, and dizziness), making it a second-line choice for routine menstrual pain.
* **B. Ketorolac:** This is an extremely potent analgesic primarily used for short-term management of severe acute pain (post-operative). It is not the standard of care for dysmenorrhea due to its high risk of nephrotoxicity and GI bleeding.
* **D. Naproxen:** Although effective and frequently used for dysmenorrhea due to its long half-life, it lacks the specific receptor-blocking property of Mefenamic acid.
**High-Yield Clinical Pearls for NEET-PG:**
* **Mefenamic Acid (Fenamate):** Also used in Menorrhagia as it reduces blood loss by 20-30%.
* **Side Effect:** A unique side effect of Mefenamic acid is **diarrhea** and occasionally hemolytic anemia.
* **DOC for PDA:** Ibuprofen (or Indomethacin) is the drug of choice for the closure of Patent Ductus Arteriosus.
* **DOC for Acute Gout:** NSAIDs (like Indomethacin or Naproxen) are first-line, but Mefenamic acid is not typically used.
More Analgesics and Anti-inflammatory Drugs Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
